Pharma · Private company
Hoffmann-La Roche
Track this companyFree. Adds Hoffmann-La Roche to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs70From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline70
- AntihistaminePhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- BendamustinePhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- CarfilzomibPhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CevostamabPhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DaratumumabPhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DivarasibPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ElotuzumabPhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- EnicepatidePhase 3 · Obesity or OverweightClinicalTrials.gov · fetched Nov 12, 2026
- GlofitamabPhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- OcrelizumabPhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PomalidomidePhase 3 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TocilizumabPhase 3 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TrontinemabPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AbirateronePhase 2 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Chemotherapy (Gemcitabine + Carboplatin or Eribulin)Phase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Englumafusp alfaPhase 2 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EtoposidePhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Relapsed or Refractory Aggressive B-Cell Non-Hodgkins LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- GlofitamabPhase 2 · Relapsed or Refractory Aggressive B-Cell Non-Hodgkins LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- GlofitamabPhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- GlofitamabPhase 2 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- IfosfamidePhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- InavolisibPhase 2 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- IpatasertibPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- NXT007Phase 2 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 2 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 2 · Relapsed or Refractory Aggressive B-Cell Non-Hodgkins LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 2 · Relapsed or Refractory Aggressive B-Cell Non-Hodgkins LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 2 · Mature B-Cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RO7568282Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RO7568282Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SGN-LIV1APhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- SPK-8011QQPhase 2 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- TocilizumabPhase 2 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- InavolisibPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- MosunetuzumabPhase 1 · Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Ocrelizumab Co-formulated With rHuPH20Phase 1 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 1 · Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RO7663498Phase 1 · Diabetic RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- RO7795081Phase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- SY-5609Phase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- TiragolumabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- TocilizumabPhase 1 · Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 1 · Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Activated Prothrombin Complex ConcentrateVon Willebrand Disease, Type 3ClinicalTrials.gov · fetched Nov 12, 2026
- Factor VIII ConcentratesVon Willebrand Disease, Type 3ClinicalTrials.gov · fetched Nov 12, 2026
- Recombinant Activated Factor VIIVon Willebrand Disease, Type 3ClinicalTrials.gov · fetched Nov 12, 2026
- RisdiplamMuscular Atrophy, SpinalClinicalTrials.gov · fetched Nov 12, 2026
- Von Willebrand Factor ConcentratesVon Willebrand Disease, Type 3ClinicalTrials.gov · fetched Nov 12, 2026
- Von Willebrand Factor Concentrates and Factor VIII ConcentratesVon Willebrand Disease, Type 3ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's DiseasePHASE2 · RECRUITING · started Nov 15, 2026ClinicalTrials.gov NCT07781657 · fetched Nov 12, 2026
- Study to Test Effects and Safety of RO7568282 in Early Parkinson's DiseasePHASE2 · RECRUITING · started Nov 10, 2026ClinicalTrials.gov NCT07781644 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)PHASE3 · RECRUITING · started Oct 6, 2026ClinicalTrials.gov NCT07541170 · fetched Nov 12, 2026
- A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseasePHASE3 · RECRUITING · started Oct 2, 2026ClinicalTrials.gov NCT07717411 · fetched Nov 12, 2026
- A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney FunctionsPHASE1 · RECRUITING · started Sep 9, 2026ClinicalTrials.gov NCT07741604 · fetched Nov 12, 2026
- A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia APHASE1_PHASE2 · RECRUITING · started Sep 8, 2026ClinicalTrials.gov NCT07226206 · fetched Nov 12, 2026
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaPHASE3 · RECRUITING · started Jun 23, 2026ClinicalTrials.gov NCT07555938 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic RetinopathyPHASE1 · RECRUITING · started Jun 18, 2026ClinicalTrials.gov NCT07588100 · fetched Nov 12, 2026
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesPHASE3 · RECRUITING · started Mar 23, 2026ClinicalTrials.gov NCT07351058 · fetched Nov 12, 2026
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesPHASE3 · RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07351045 · fetched Nov 12, 2026
- A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerPHASE2 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07287150 · fetched Nov 12, 2026
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentACTIVE_NOT_RECRUITING · started Apr 29, 2025ClinicalTrials.gov NCT06883240 · fetched Nov 12, 2026
- Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLPHASE2 · RECRUITING · started Mar 5, 2025ClinicalTrials.gov NCT06806033 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple SclerosisPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 17, 2024ClinicalTrials.gov NCT07667322 · fetched Nov 12, 2026
- A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene TherapyPHASE4 · ACTIVE_NOT_RECRUITING · started May 30, 2024ClinicalTrials.gov NCT05861986 · fetched Nov 12, 2026
- A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaPHASE3 · RECRUITING · started Oct 22, 2023ClinicalTrials.gov NCT06084936 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia APHASE1_PHASE2 · RECRUITING · started Sep 21, 2023ClinicalTrials.gov NCT05987449 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationPHASE1_PHASE2 · RECRUITING · started Jun 20, 2023ClinicalTrials.gov NCT05789082 · fetched Nov 12, 2026
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaPHASE1_PHASE2 · RECRUITING · started Nov 16, 2022ClinicalTrials.gov NCT05533775 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaPHASE1 · RECRUITING · started Mar 7, 2022ClinicalTrials.gov NCT05091424 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)PHASE1 · RECRUITING · started Oct 22, 2021ClinicalTrials.gov NCT04929223 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 26, 2020ClinicalTrials.gov NCT04544436 · fetched Nov 12, 2026
- A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple SclerosisPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2020ClinicalTrials.gov NCT04075266 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's LymphomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 13, 2019ClinicalTrials.gov NCT04077723 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1_PHASE2 · RECRUITING · started Mar 30, 2018ClinicalTrials.gov NCT03424005 · fetched Nov 12, 2026